EX-FILING FEES 5 dp215008_exfilingfees.htm EXHIBIT 107

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form F-3

(Form Type)

 

AC Immune SA

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type
  Security Class
Title
  Fee Calculation
or Carry Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering
Price
  Fee
Rate
  Amount of
Registration
Fee
 

Carry
Forward

Form
Type 

 

Carry

Forward 

File

Number 

  Carry
Forward
Initial
Effective
Date
  Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
Newly Registered Securities

Fees to Be

Paid

  Equity   Common Shares   Rule 457(o)   (1)   (1)   (1)       (1)                
    Debt   Securities   Rule 457(o)   (1)   (1)   (1)       (1)                
    Other   Warrants   Rule 457(o)   (1)   (1)   (1)       (1)                
    Other   Purchase Contracts   Rule 457(o)   (1)   (1)   (1)       (1)                
    Other   Subscription Rights   Rule 457(o)   (1)   (1)   (1)       (1)                
    Other   Units   Rule 457(o)   (1)   (1)   (1)       (1)                
    Unallocated (Universal) Shelf   Unallocated (Universal) Shelf   Rule 457(o)   (1)   (1)   $350,000,000   0.00014760   $51,660                

Fees

Previously

Paid

  N/A   N/A   N/A   N/A   N/A   N/A       N/A                
Carry Forward Securities

Carry

Forward

Securities

  Equity   Common Shares   415(a)(6)   (2)       (2)       (2)   F-3   333-255576   May 5, 2021   (2)

Carry

Forward

Securities

  Debt   Securities   415(a)(6)   (2)       (2)       (2)   F-3   333-255576   May 5, 2021   (2)

Carry

Forward

Securities

  Other   Warrants   415(a)(6)   (2)       (2)       (2)   F-3   333-255576   May 5, 2021   (2)

Carry

Forward

Securities

  Other   Purchase Contracts   415(a)(6)   (2)       (2)       (2)   F-3   333-255576   May 5, 2021   (2)

Carry

Forward

Securities

  Other   Subscription Rights   415(a)(6)   (2)       (2)       (2)   F-3   333-255576   May 5, 2021   (2)

Carry

Forward

Securities

  Other   Units   415(a)(6)   (2)       (2)       (2)   F-3   333-255576   May 5, 2021   (2)

Carry

Forward

Securities

  Unallocated (Universal) Shelf   Unallocated (Universal) Shelf   415(a)(6)   (2)       $291,745,726 (2)   0.00014760   $43,061.67   F-3   333-255576   May 5, 2021   (2)
Total Offering Amounts       $58,254,274        $8,598.33                
Total Fees Previously Paid       $58,106,310(3)        $8,576.49                
Total Fee Offsets               N/A                
Net Fee Due               $21.84                

 

(1)Omitted pursuant to General Instruction II.C to Form F-3. The amount to be registered consists of up to $350,000,000 of an indeterminate amount of common shares, debt securities, warrants, purchase contracts, subscription rights and/or units that may be offered and sold from time to time in one or more offerings.

 

(2)AC Immune SA (the “Registrant”) previously filed a registration statement on Form F-3 (File No. 333-255576), initially filed on April 28, 2021 and declared effective on May 5, 2021 (the “2021 Prior Registration Statement”) and which registered the offer and sale of an indeterminate number of common shares, principal amount of debt securities, purchase contracts, warrants to purchase common shares, debt securities or other securities, units and subscription rights (collectively, the “Shelf Securities”) having an aggregate initial offering price not to exceed $350,000,000. The 2021 Prior Registration Statement was not fully used and as of July 26, 2024, $291,745,726 of the Shelf Securities remain unsold. The Registrant expects to carry forward to this registration statement the Unsold Securities pursuant to Rule 415(a)(6) under the Securities Act of 1933, as amended (the “Securities Act”). To the extent that, after the filing date hereof and prior to the effectiveness of this registration statement, the Registrant sells any Unsold Securities pursuant to the Prior Registration Statement, the Registrant will identify in a pre-effective amendment to this registration statement the updated amount of Unsold Securities from the 2021 Prior Registration Statement to be included in this registration statement pursuant to Rule 415(a)(6). Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the 2021 Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement.

 

(3)The Registrant on March 14, 2024 filed this registration statement on Form F-3 (File No. 333-277940) which registered the offer and sale of an indeterminate number of common shares, principal amount of debt securities, purchase contracts, warrants to purchase common shares, debt securities or other securities, units and subscription rights (collectively, the “Shelf Securities”) having an aggregate initial offering price not to exceed $350,000,000. At the time of filing, the 2021 Prior Registration Statement was not fully used and $291,893,690 of the Shelf Securities remained unsold. Since the initial filing of this registration statement, there has been a decrease of $147,964 in the amount of unsold shares under the 2021 Prior Registration Statement. The Registrant previously paid a registration fee of $8,576.49 in connection with the initial filing of this registration statement. The $8,576.49 previously paid filing fees relating to such Unsold Securities under the 2021 Prior Registration Statement will continue to be applied to such Unsold Securities registered on this registration statement. The updated amount of unsold securities results in $21.84 in net fee due.